Literature DB >> 25295768

Managing the pain of knee osteoarthritis.

Scott A Hrnack1, F Alan Barber.   

Abstract

Pain from knee osteoarthritis creates a significant burden for symptomatic patients, who are often forced to change their lifestyle because of their symptoms. Activity modification, therapy, weight loss, nonsteroidal anti-inflammatory drugs, shoe orthotics, bracing, and injections are the nonoperative options available. New technologies are also emerging in the treatment of knee osteoarthritis. Ultimately, these therapeutic modalities should reduce pain and increase the overall functioning of patients. These nonoperative modalities give the clinician several effective options before surgical management is considered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25295768     DOI: 10.3810/psm.2014.09.2077

Source DB:  PubMed          Journal:  Phys Sportsmed        ISSN: 0091-3847            Impact factor:   2.241


  5 in total

Review 1.  How does surgery compare with advanced intra-articular therapies in knee osteoarthritis: current thoughts.

Authors:  Peter Wehling; Carsten Moser; William Maixner
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-04-18       Impact factor: 5.346

2.  Influence of IL13 on Periostin Secretion by Synoviocytes in Osteoarthritis.

Authors:  Tatsuya Moue; Yutaro Tajika; Shintaro Ishikawa; Yasuaki Kanada; Takayuki Okumo; Kazuhito Asano; Tadashi Hisamitsu
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

3.  Influence of Periostin on Synoviocytes in Knee Osteoarthritis.

Authors:  Yutaro Tajika; Tatsuya Moue; Shintaro Ishikawa; Kazuhito Asano; Takayuki Okumo; Hiroshi Takagi; Tadashi Hisamitsu
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

4.  Effects of knee sleeves on coordination of lower-limb segments in healthy adults during level walking and one-leg hopping.

Authors:  Chang-Yong Ko; Yunhee Chang; Bora Jeong; Sungjae Kang; Jeicheong Ryu; Gyoosuk Kim
Journal:  PeerJ       Date:  2017-05-18       Impact factor: 2.984

5.  Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Authors:  Germain Honvo; Raveendhara R Bannuru; Olivier Bruyère; Francois Rannou; Gabriel Herrero-Beaumont; Daniel Uebelhart; Cyrus Cooper; Nigel Arden; Philip G Conaghan; Jean-Yves Reginster; Thierry Thomas; Tim McAlindon
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.